The Democratic Republic of the Congo (DR Congo) is currently facing its 17th outbreak of Ebola, specifically the Bundibugyo strain, which has not been seen for over a decade. As of now, more than 600 cases have been reported, with at least 179 confirmed deaths. Health experts, including World Health Organization advisor Dr. Vasee Moorthy, have indicated that it might take between six to nine months to develop an effective vaccine against this strain, as the only available vaccine is effective only against the Zaire species. The outbreak, which may have been ongoing for weeks before its detection on April 24, is exacerbated by a perfect storm of factors such as ongoing conflict, refugee movements, and a fragile health system. The epicenter of the outbreak is in Ituri province, where insecurity has intensified, displacing over 100,000 people. This instability complicates disease tracking and response efforts, while the overlap of Ebola symptoms with other diseases like Mpox and Malaria makes identification difficult. Additionally, the country’s proximity to wild animals increases the risk of zoonotic disease transmission.